Oxford Nanopore Technologies (LON:ONT) Price Target Lowered to GBX 200 at Berenberg Bank

Oxford Nanopore Technologies (LON:ONT) had its price objective lowered by Berenberg Bank from GBX 220 to GBX 200 in a report issued on Wednesday,Digital Look reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 52.67% from the stock’s current price.

Other equities research analysts have also issued reports about the company. Peel Hunt reissued a “hold” rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a report on Monday, July 13th. Royal Bank Of Canada reiterated an “outperform” rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Finally, Citigroup downgraded shares of Oxford Nanopore Technologies to a “buy” rating in a report on Monday, July 20th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Oxford Nanopore Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 200.75.

Oxford Nanopore Technologies Trading Up 7.2%

Shares of ONT stock opened at GBX 131 on Wednesday. Oxford Nanopore Technologies has a 1-year low of GBX 95.61 and a 1-year high of GBX 215.60. The company has a market cap of £1.28 billion, a price-to-earnings ratio of -8.68 and a beta of 0.91. The company has a debt-to-equity ratio of 8.96, a current ratio of 3.56 and a quick ratio of 6.01. The stock has a 50 day simple moving average of GBX 118.16 and a 200-day simple moving average of GBX 122.69.

Oxford Nanopore Technologies (LON:ONT) last released its quarterly earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.